Global Cancer (Tumor) Profiling Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

November 2018 | 121 pages | ID: GBA13AFA561EN
GlobalInfoResearch

Abstracts

The cancer/tumor profiling market in terms of technology has been segmented into next generation sequencing (NGS), quantitative polymerase chain reaction (QPCR), immunohistochemistry (IHC), in-situ hybridization (ISH), and microarray, based on technology.

Scope of the Report:

Europe held the second largest share of 27.7% in the global cancer/tumor profiling market in 2017.
The worldwide market for Cancer (Tumor) Profiling is expected to grow at a CAGR of roughly 11.0% over the next five years, will reach 9830 million US$ in 2023, from 5260 million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the Cancer (Tumor) Profiling in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

• Illumina, Inc.
• Qiagen N.V.
• Neogenomics Laboratories, Inc.
• HTG Molecular Diagnostics, Inc.
• Genomic Health Inc.
• Caris Life Sciences
• Helomics Corporation
• Nanostring Technologies, Inc.
• Oxford Gene Technology
• Ribomed Biotechnologies, Inc.

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Immunoassay
• Hybridization
• NGS
• Mass Spectrometry

Market Segment by Applications, can be divided into

• Clinical
• Research

There are 15 Chapters to deeply display the global Cancer (Tumor) Profiling market.

Chapter 1, to describe Cancer (Tumor) Profiling Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Cancer (Tumor) Profiling, with sales, revenue, and price of Cancer (Tumor) Profiling, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Cancer (Tumor) Profiling, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Cancer (Tumor) Profiling market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Cancer (Tumor) Profiling sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Cancer (Tumor) Profiling Introduction
1.2 Market Analysis by Type
  1.2.1 Immunoassay
  1.2.2 Hybridization
  1.2.3 NGS
  1.2.4 Mass Spectrometry
1.3 Market Analysis by Applications
  1.3.1 Clinical
  1.3.2 Research
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Illumina, Inc.
  2.1.1 Business Overview
  2.1.2 Cancer (Tumor) Profiling Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Illumina, Inc. Cancer (Tumor) Profiling Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Qiagen N.V.
  2.2.1 Business Overview
  2.2.2 Cancer (Tumor) Profiling Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Qiagen N.V. Cancer (Tumor) Profiling Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Neogenomics Laboratories, Inc.
  2.3.1 Business Overview
  2.3.2 Cancer (Tumor) Profiling Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Neogenomics Laboratories, Inc. Cancer (Tumor) Profiling Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 HTG Molecular Diagnostics, Inc.
  2.4.1 Business Overview
  2.4.2 Cancer (Tumor) Profiling Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 HTG Molecular Diagnostics, Inc. Cancer (Tumor) Profiling Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Genomic Health Inc.
  2.5.1 Business Overview
  2.5.2 Cancer (Tumor) Profiling Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Genomic Health Inc. Cancer (Tumor) Profiling Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Caris Life Sciences
  2.6.1 Business Overview
  2.6.2 Cancer (Tumor) Profiling Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Caris Life Sciences Cancer (Tumor) Profiling Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Helomics Corporation
  2.7.1 Business Overview
  2.7.2 Cancer (Tumor) Profiling Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Helomics Corporation Cancer (Tumor) Profiling Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Nanostring Technologies, Inc.
  2.8.1 Business Overview
  2.8.2 Cancer (Tumor) Profiling Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Nanostring Technologies, Inc. Cancer (Tumor) Profiling Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Oxford Gene Technology
  2.9.1 Business Overview
  2.9.2 Cancer (Tumor) Profiling Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Oxford Gene Technology Cancer (Tumor) Profiling Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Ribomed Biotechnologies, Inc.
  2.10.1 Business Overview
  2.10.2 Cancer (Tumor) Profiling Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Ribomed Biotechnologies, Inc. Cancer (Tumor) Profiling Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL CANCER (TUMOR) PROFILING SALES, REVENUE, MARKET SHARE AND COMPETITION BY MANUFACTURER (2016-2017)

3.1 Global Cancer (Tumor) Profiling Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Cancer (Tumor) Profiling Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
  3.3.1 Top 3 Cancer (Tumor) Profiling Manufacturer Market Share in 2017
  3.3.2 Top 6 Cancer (Tumor) Profiling Manufacturer Market Share in 2017
3.4 Market Competition Trend

4 GLOBAL CANCER (TUMOR) PROFILING MARKET ANALYSIS BY REGIONS

4.1 Global Cancer (Tumor) Profiling Sales, Revenue and Market Share by Regions
  4.1.1 Global Cancer (Tumor) Profiling Sales and Market Share by Regions (2013-2018)
  4.1.2 Global Cancer (Tumor) Profiling Revenue and Market Share by Regions (2013-2018)
4.2 North America Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
4.3 Europe Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
4.5 South America Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)

5 NORTH AMERICA CANCER (TUMOR) PROFILING BY COUNTRIES

5.1 North America Cancer (Tumor) Profiling Sales, Revenue and Market Share by Countries
  5.1.1 North America Cancer (Tumor) Profiling Sales and Market Share by Countries (2013-2018)
  5.1.2 North America Cancer (Tumor) Profiling Revenue and Market Share by Countries (2013-2018)
5.2 United States Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
5.3 Canada Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
5.4 Mexico Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)

6 EUROPE CANCER (TUMOR) PROFILING BY COUNTRIES

6.1 Europe Cancer (Tumor) Profiling Sales, Revenue and Market Share by Countries
  6.1.1 Europe Cancer (Tumor) Profiling Sales and Market Share by Countries (2013-2018)
  6.1.2 Europe Cancer (Tumor) Profiling Revenue and Market Share by Countries (2013-2018)
6.2 Germany Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
6.3 UK Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
6.4 France Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
6.5 Russia Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
6.6 Italy Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)

7 ASIA-PACIFIC CANCER (TUMOR) PROFILING BY COUNTRIES

7.1 Asia-Pacific Cancer (Tumor) Profiling Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Cancer (Tumor) Profiling Sales and Market Share by Countries (2013-2018)
  7.1.2 Asia-Pacific Cancer (Tumor) Profiling Revenue and Market Share by Countries (2013-2018)
7.2 China Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
7.3 Japan Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
7.4 Korea Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
7.5 India Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)

8 SOUTH AMERICA CANCER (TUMOR) PROFILING BY COUNTRIES

8.1 South America Cancer (Tumor) Profiling Sales, Revenue and Market Share by Countries
  8.1.1 South America Cancer (Tumor) Profiling Sales and Market Share by Countries (2013-2018)
  8.1.2 South America Cancer (Tumor) Profiling Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
8.3 Argentina Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
8.4 Colombia Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA CANCER (TUMOR) PROFILING BY COUNTRIES

9.1 Middle East and Africa Cancer (Tumor) Profiling Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Cancer (Tumor) Profiling Sales and Market Share by Countries (2013-2018)
  9.1.2 Middle East and Africa Cancer (Tumor) Profiling Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
9.3 UAE Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
9.4 Egypt Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
9.5 Nigeria Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
9.6 South Africa Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)

10 GLOBAL CANCER (TUMOR) PROFILING MARKET SEGMENT BY TYPE

10.1 Global Cancer (Tumor) Profiling Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Cancer (Tumor) Profiling Sales and Market Share by Type (2013-2018)
  10.1.2 Global Cancer (Tumor) Profiling Revenue and Market Share by Type (2013-2018)
10.2 Immunoassay Sales Growth and Price
  10.2.1 Global Immunoassay Sales Growth (2013-2018)
  10.2.2 Global Immunoassay Price (2013-2018)
10.3 Hybridization Sales Growth and Price
  10.3.1 Global Hybridization Sales Growth (2013-2018)
  10.3.2 Global Hybridization Price (2013-2018)
10.4 NGS Sales Growth and Price
  10.4.1 Global NGS Sales Growth (2013-2018)
  10.4.2 Global NGS Price (2013-2018)
10.5 Mass Spectrometry Sales Growth and Price
  10.5.1 Global Mass Spectrometry Sales Growth (2013-2018)
  10.5.2 Global Mass Spectrometry Price (2013-2018)

11 GLOBAL CANCER (TUMOR) PROFILING MARKET SEGMENT BY APPLICATION

11.1 Global Cancer (Tumor) Profiling Sales Market Share by Application (2013-2018)
11.2 Clinical Sales Growth (2013-2018)
11.3 Research Sales Growth (2013-2018)

12 CANCER (TUMOR) PROFILING MARKET FORECAST (2018-2023)

12.1 Global Cancer (Tumor) Profiling Sales, Revenue and Growth Rate (2018-2023)
12.2 Cancer (Tumor) Profiling Market Forecast by Regions (2018-2023)
  12.2.1 North America Cancer (Tumor) Profiling Market Forecast (2018-2023)
  12.2.2 Europe Cancer (Tumor) Profiling Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Cancer (Tumor) Profiling Market Forecast (2018-2023)
  12.2.4 South America Cancer (Tumor) Profiling Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Cancer (Tumor) Profiling Market Forecast (2018-2023)
12.3 Cancer (Tumor) Profiling Market Forecast by Type (2018-2023)
  12.3.1 Global Cancer (Tumor) Profiling Sales Forecast by Type (2018-2023)
  12.3.2 Global Cancer (Tumor) Profiling Market Share Forecast by Type (2018-2023)
12.4 Cancer (Tumor) Profiling Market Forecast by Application (2018-2023)
  12.4.1 Global Cancer (Tumor) Profiling Sales Forecast by Application (2018-2023)
  12.4.2 Global Cancer (Tumor) Profiling Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Cancer (Tumor) Profiling Picture
Table Product Specifications of Cancer (Tumor) Profiling
Figure Global Sales Market Share of Cancer (Tumor) Profiling by Types in 2017
Table Cancer (Tumor) Profiling Types for Major Manufacturers
Figure Immunoassay Picture
Figure Hybridization Picture
Figure NGS Picture
Figure Mass Spectrometry Picture
Figure Cancer (Tumor) Profiling Sales Market Share by Applications in 2017
Figure Clinical Picture
Figure Research Picture
Figure United States Cancer (Tumor) Profiling Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Cancer (Tumor) Profiling Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Cancer (Tumor) Profiling Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Cancer (Tumor) Profiling Revenue (Value) and Growth Rate (2013-2023)
Figure France Cancer (Tumor) Profiling Revenue (Value) and Growth Rate (2013-2023)
Figure UK Cancer (Tumor) Profiling Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Cancer (Tumor) Profiling Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Cancer (Tumor) Profiling Revenue (Value) and Growth Rate (2013-2023)
Figure China Cancer (Tumor) Profiling Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Cancer (Tumor) Profiling Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Cancer (Tumor) Profiling Revenue (Value) and Growth Rate (2013-2023)
Figure India Cancer (Tumor) Profiling Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Cancer (Tumor) Profiling Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Cancer (Tumor) Profiling Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Cancer (Tumor) Profiling Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Cancer (Tumor) Profiling Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Cancer (Tumor) Profiling Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Cancer (Tumor) Profiling Revenue (Value) and Growth Rate (2013-2023)
Table Illumina, Inc. Basic Information, Manufacturing Base and Competitors
Table Illumina, Inc. Cancer (Tumor) Profiling Type and Applications
Table Illumina, Inc. Cancer (Tumor) Profiling Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Qiagen N.V. Basic Information, Manufacturing Base and Competitors
Table Qiagen N.V. Cancer (Tumor) Profiling Type and Applications
Table Qiagen N.V. Cancer (Tumor) Profiling Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Neogenomics Laboratories, Inc. Basic Information, Manufacturing Base and Competitors
Table Neogenomics Laboratories, Inc. Cancer (Tumor) Profiling Type and Applications
Table Neogenomics Laboratories, Inc. Cancer (Tumor) Profiling Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table HTG Molecular Diagnostics, Inc. Basic Information, Manufacturing Base and Competitors
Table HTG Molecular Diagnostics, Inc. Cancer (Tumor) Profiling Type and Applications
Table HTG Molecular Diagnostics, Inc. Cancer (Tumor) Profiling Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Genomic Health Inc. Basic Information, Manufacturing Base and Competitors
Table Genomic Health Inc. Cancer (Tumor) Profiling Type and Applications
Table Genomic Health Inc. Cancer (Tumor) Profiling Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Caris Life Sciences Basic Information, Manufacturing Base and Competitors
Table Caris Life Sciences Cancer (Tumor) Profiling Type and Applications
Table Caris Life Sciences Cancer (Tumor) Profiling Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Helomics Corporation Basic Information, Manufacturing Base and Competitors
Table Helomics Corporation Cancer (Tumor) Profiling Type and Applications
Table Helomics Corporation Cancer (Tumor) Profiling Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Nanostring Technologies, Inc. Basic Information, Manufacturing Base and Competitors
Table Nanostring Technologies, Inc. Cancer (Tumor) Profiling Type and Applications
Table Nanostring Technologies, Inc. Cancer (Tumor) Profiling Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Oxford Gene Technology Basic Information, Manufacturing Base and Competitors
Table Oxford Gene Technology Cancer (Tumor) Profiling Type and Applications
Table Oxford Gene Technology Cancer (Tumor) Profiling Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ribomed Biotechnologies, Inc. Basic Information, Manufacturing Base and Competitors
Table Ribomed Biotechnologies, Inc. Cancer (Tumor) Profiling Type and Applications
Table Ribomed Biotechnologies, Inc. Cancer (Tumor) Profiling Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Cancer (Tumor) Profiling Sales by Manufacturer (2016-2017)
Figure Global Cancer (Tumor) Profiling Sales Market Share by Manufacturer in 2016
Figure Global Cancer (Tumor) Profiling Sales Market Share by Manufacturer in 2017
Table Global Cancer (Tumor) Profiling Revenue by Manufacturer (2016-2017)
Figure Global Cancer (Tumor) Profiling Revenue Market Share by Manufacturer in 2016
Figure Global Cancer (Tumor) Profiling Revenue Market Share by Manufacturer in 2017
Figure Top 3 Cancer (Tumor) Profiling Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Cancer (Tumor) Profiling Manufacturer (Revenue) Market Share in 2017
Figure Global Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
Figure Global Cancer (Tumor) Profiling Revenue and Growth Rate (2013-2018)
Table Global Cancer (Tumor) Profiling Sales by Regions (2013-2018)
Table Global Cancer (Tumor) Profiling Sales Market Share by Regions (2013-2018)
Table Global Cancer (Tumor) Profiling Revenue by Regions (2013-2018)
Figure Global Cancer (Tumor) Profiling Revenue Market Share by Regions in 2013
Figure Global Cancer (Tumor) Profiling Revenue Market Share by Regions in 2017
Figure North America Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
Figure Europe Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
Figure South America Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
Figure North America Cancer (Tumor) Profiling Revenue and Growth Rate (2013-2018)
Table North America Cancer (Tumor) Profiling Sales by Countries (2013-2018)
Table North America Cancer (Tumor) Profiling Sales Market Share by Countries (2013-2018)
Figure North America Cancer (Tumor) Profiling Sales Market Share by Countries in 2013
Figure North America Cancer (Tumor) Profiling Sales Market Share by Countries in 2017
Table North America Cancer (Tumor) Profiling Revenue by Countries (2013-2018)
Table North America Cancer (Tumor) Profiling Revenue Market Share by Countries (2013-2018)
Figure North America Cancer (Tumor) Profiling Revenue Market Share by Countries in 2013
Figure North America Cancer (Tumor) Profiling Revenue Market Share by Countries in 2017
Figure United States Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
Figure Canada Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
Figure Mexico Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
Figure Europe Cancer (Tumor) Profiling Revenue and Growth Rate (2013-2018)
Table Europe Cancer (Tumor) Profiling Sales by Countries (2013-2018)
Table Europe Cancer (Tumor) Profiling Sales Market Share by Countries (2013-2018)
Table Europe Cancer (Tumor) Profiling Revenue by Countries (2013-2018)
Figure Europe Cancer (Tumor) Profiling Revenue Market Share by Countries in 2016
Figure Europe Cancer (Tumor) Profiling Revenue Market Share by Countries in 2017
Figure Germany Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
Figure UK Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
Figure France Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
Figure Russia Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
Figure Italy Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Cancer (Tumor) Profiling Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Cancer (Tumor) Profiling Sales by Countries (2013-2018)
Table Asia-Pacific Cancer (Tumor) Profiling Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Cancer (Tumor) Profiling Sales Market Share by Countries 2017
Table Asia-Pacific Cancer (Tumor) Profiling Revenue by Countries (2013-2018)
Figure Asia-Pacific Cancer (Tumor) Profiling Revenue Market Share by Countries 2017
Figure China Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
Figure Japan Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
Figure Korea Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
Figure India Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
Figure Southeast Asia Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
Figure South America Cancer (Tumor) Profiling Revenue and Growth Rate (2013-2018)
Table South America Cancer (Tumor) Profiling Sales by Countries (2013-2018)
Table South America Cancer (Tumor) Profiling Sales Market Share by Countries (2013-2018)
Figure South America Cancer (Tumor) Profiling Sales Market Share by Countries in 2017
Table South America Cancer (Tumor) Profiling Revenue by Countries (2013-2018)
Table South America Cancer (Tumor) Profiling Revenue Market Share by Countries (2013-2018)
Figure South America Cancer (Tumor) Profiling Revenue Market Share by Countries in 2017
Figure Brazil Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
Figure Argentina Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
Figure Colombia Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Cancer (Tumor) Profiling Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Cancer (Tumor) Profiling Sales by Countries (2013-2018)
Table Middle East and Africa Cancer (Tumor) Profiling Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Cancer (Tumor) Profiling Sales Market Share by Countries in 2017
Table Middle East and Africa Cancer (Tumor) Profiling Revenue by Countries (2013-2018)
Table Middle East and Africa Cancer (Tumor) Profiling Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Cancer (Tumor) Profiling Revenue Market Share by Countries in 2013
Figure Middle East and Africa Cancer (Tumor) Profiling Revenue Market Share by Countries in 2017
Figure Saudi Arabia Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
Figure UAE Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
Figure Egypt Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
Figure Nigeria Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
Figure South Africa Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)
Table Global Cancer (Tumor) Profiling Sales by Type (2013-2018)
Table Global Cancer (Tumor) Profiling Sales Share by Type (2013-2018)
Table Global Cancer (Tumor) Profiling Revenue by Type (2013-2018)
Table Global Cancer (Tumor) Profiling Revenue Share by Type (2013-2018)
Figure Global Immunoassay Sales Growth (2013-2018)
Figure Global Immunoassay Price (2013-2018)
Figure Global Hybridization Sales Growth (2013-2018)
Figure Global Hybridization Price (2013-2018)
Figure Global NGS Sales Growth (2013-2018)
Figure Global NGS Price (2013-2018)
Figure Global Mass Spectrometry Sales Growth (2013-2018)
Figure Global Mass Spectrometry Price (2013-2018)
Table Global Cancer (Tumor) Profiling Sales by Application (2013-2018)
Table Global Cancer (Tumor) Profiling Sales Share by Application (2013-2018)
Figure Global Research Sales Growth (2013-2018)
Figure Global Cancer (Tumor) Profiling Sales, Revenue and Growth Rate (2018-2023)
Table Global Cancer (Tumor) Profiling Sales Forecast by Regions (2018-2023)
Table Global Cancer (Tumor) Profiling Market Share Forecast by Regions (2018-2023)
Figure North America Sales Cancer (Tumor) Profiling Market Forecast (2018-2023)
Figure Europe Sales Cancer (Tumor) Profiling Market Forecast (2018-2023)
Figure Asia-Pacific Sales Cancer (Tumor) Profiling Market Forecast (2018-2023)
Figure South America Sales Cancer (Tumor) Profiling Market Forecast (2018-2023)
Figure Middle East and Africa Sales Cancer (Tumor) Profiling Market Forecast (2018-2023)
Table Global Cancer (Tumor) Profiling Sales Forecast by Type (2018-2023)
Table Global Cancer (Tumor) Profiling Market Share Forecast by Type (2018-2023)
Table Global Cancer (Tumor) Profiling Sales Forecast by Application (2018-2023)
Table Global Cancer (Tumor) Profiling Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List